The main purpose of this legislation is to improve access to innovative medical devices known as "breakthrough devices" for Medicare beneficiaries. It aims to ensure that these devices, which can significantly enhance patient care, are covered by Medicare in a timely manner. Key provisions of the legislation include the establishment of a transitional coverage period for breakthrough devices. This period lasts four years from the time a device is designated as a breakthrough by the Secretary of Health and Human Services.